Skip to main content
Leiden University
Scholarly Publications
Home
Submit
About
Select Collection
All collections
Academic speeches
Dissertations
Faculty of Archaeology
Faculty of Governance and Global Affairs
Faculty of Humanities
Faculty of Science
Faculty of Social and Behavioural Sciences
Leiden Journals, Conference Proceedings and Books
Leiden Law School
Leiden University Press
Medicine / Leiden University Medical Centre (LUMC)
Research output UL
Search box
Your Search
Enabled Filters
(-)
= Greenwald, M.
Sort Options
Date (year)
Author / Creator
Title
Refine Results
Resource Type
Article / Letter to editor
(3)
+
-
Availability
Open access
(1)
+
-
Metadata Only
(2)
+
-
Creation Date
2017
(2)
+
-
Faculty
Leiden University Medical Center (LUMC)
(3)
+
-
Collection
Medicine / Leiden University Medical Centre (LUMC)
(3)
+
-
Author
Bono, S. de
(3)
+
-
Dougados, M.
(3)
+
-
Drescher, E.
(3)
+
-
Emery, P.
(3)
+
-
Greenwald, M.
(3)
+
-
Heijde, D. van der
(3)
+
-
Rooney, T.
(3)
+
-
Schlichting, D.
(3)
+
-
Torre, I. de la
(3)
+
-
Beattie, S.
(2)
+
-
Chen, Y.C.
(2)
+
-
Liu, J.J.
(2)
+
-
Witt, S.
(2)
+
-
Show more
Language
en
(3)
+
-
Search results
(1 - 3 of 3)
show grid
show list
save search
Genovese, M.; Heijde, D. van der; Dougados, M.; Chen, Y.; Greenwald, M.; Drescher, E.; ... ; Emery, P.
2017
BARICITINIB INHIBITS RADIOGRAPHIC PROGRESSION OF STRUCTURAL JOINT DAMAGE AT 1 YEAR IN PATIENTS WITH RHEUMATOID ARTHRITIS (RA) AND AN INADEQUATE RESPONSE TO CONVENTIONAL SYNTHETIC DISEASE-MODIFYING ANTIRHEUMATIC DRUGS (CSDMARDS)
Article / Letter to editor
metadata only
Dougados, M.; Heijde, D. van der; Chen, Y.C.; Greenwald, M.; Drescher, E.; Liu, J.J.; ... ; Emery, P.
2017
Baricitinib in patients with inadequate response or intolerance to conventional synthetic DMARDs: results from the RA-BUILD study
Article / Letter to editor
open access
Dougados, M.; Heijde, D. van der; Chen, Y.C.; Greenwald, M.; Drescher, E.; Liu, J.J.; ... ; Bookman, A.
2016
Baricitinib, an Oral Janus Kinase (JAK) 1/JAK2 Inhibitor, in Patients with Active Rheumatoid Arthritis (RA) and an Inadequate Response to cDMARD Therapy: Results of the Phase 3 RA-BUILD Study
Article / Letter to editor
metadata only